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Abstract: Stroke or cerebrovascular injury is the leading cause of disability and the third leading cause of deaths worldwide. 
After the initial ischemic injury, sympathetic signals are transmitted to the spleen and a compromised blood-brain barrier, 
coupled with expression of adhesion molecules by the vascular endothelial cells permits an influx of peripheral immune 
cells. This influx of peripheral immune cells into the brain exacerbates the local brain inflammatory response, leading to 
enhanced neurodegeneration. Agmatine is a primary amine formed by decarboxylation of L-arginine synthesized in the 
mammalian brain. In this study, we determined the eff ect of agmatine on the immune response in the spleen aft er transient 
cerebral ischemia. Twenty-three hours after transient cerebral ischemia, the white pulp area was reduced and the number 
of CD11b+ macrophages and CD4+CD25+ regulatory T cells (T reg cells) were increased in the spleens in the experimental 
group as a result of alteration of the immune response in the spleen, as regulated by infl ammatory cytokines. In the agmatine 
treatment group (100 mg/kg IP), the contraction of white pulp was diminished and the number of CD11b+ macrophages and 
CD4+CD25+T reg cells were decreased. Twenty-three hours after transient cerebral ischemia, the brain infarction area was 
signifi cantly reduced (5.51±1.63% of the whole brain) in the agmatine treatment group compared to 15.02±4.28% of the whole 
brain in the experimental control group. Th ese results suggest that agmatine treatment can reduce brain infarction through 
minimizing neuroinfl ammation and can lessen the danger of post-stroke infection from depression of the immune system aft er 
stroke.
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2003). Th is infl ux of peripheral immune cells into the brain 
exacerbates the local brain inflammatory response, leading 
to infarction (the process of tissue death [necrosis] caused 
by blockage of the tissue’s blood supply) with enhanced 
neurodegeneration. Also, the altered splenic function and 
increased pro-infl ammatory cytokines are shown aft er stroke 
(Gendron et al., 2002; Offner et al., 2006; Vendrame et al., 
2006).
Previous studies have demonstrated altered splenic 
function after a stroke and increased circulating pro-
inflammatory cytokines (Gendron et al., 2002; Offner et 
al., 2006; Vendrame et al., 2006). The infiltrating cells and 
increased pro-infl ammatory cytokines negatively aff ect stroke 
outcome (Lucas et al., 2006).
 Norepinephrine and β2-adrenergic receptor stimulation 
Introduction 
Stroke is caused by occlusion of the blood supply in the 
brain aft er 6~8 minutes, thereaft er proceeding to irreversible 
neurologic degeneration. After the initial ischemic injury, a 
compromised blood-brain barrier coupled with expression of 
adhesion molecules by the vascular endothelial cells permits 
an infl ux of peripheral immune cells, including macrophages, 
neutrophils, leukocytes, and T and B cells (Emsley et al., 
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from infection and injury has been strongly implicated in the 
regulation of the immune response (Kohm & Sanders, 2001), 
and it is conceivable that brain injury might also transmit 
sympathetic signals to the spleen. 
Agmatine is formed by the decarboxylation of L-arginine 
by arginine decarboxylase (Yang & Reis, 1999). Agmatine is 
an endogenous clonidine-displacing substance, an agonist 
for the ά2-adrenergic and imidazoline receptors, and an 
antagonist at N-methyl-D-aspartate (NMDA) receptors 
(Reynolds, 1990; Li et al., 1994; Piletz et al., 1995). Agmatine 
also inhibits the release of norepinephrine from presynaptic 
terminals (Molderings et al., 2002) and can inhibit the 
induction of inducible NOS (iNOS) by infl ammatory stimuli 
(Auguet et al., 1995; Regunathan & Piletz, 2003).  However, 
the exact mechanism underlying the neuroprotective effect 
of agmatine is unclear, but it may be related to the ability of 
agmatine to inhibit the induction of iNOS and to block the 
NMDA receptor. 
The spleen accommodates the efficient phagocytosis and 
recycling of iron, the capture and destruction of pathogens, 
and the induction of adaptive immune responses. These 
discrete functions are uniquely combined in one organ 
through compartmentalization into different regions with 
adaptations that are not observed in other lymphoid organs. 
The function of the white pulp is to promote adaptive 
immune responses to bloodborne antigens. These antigens 
are delivered into the marginal sinus by circulating dendritic 
cells, or are sampled by the macrophages in the marginal 
zone. The anatomic arrangements of the APCs, B cells, and 
T cells promote the interactions required for the efficient 
development of immune responses.  
The purpose of the present study was to determine 
the morphologic changes of the rat spleen after transient 
cerebral ischemia by agmatine treatment and to verify splenic 
immune responses after transient cerebral ischemia with or 
without agmatine treatment by confi rming the changes in the 
expression of CD11b+ macrophages, CD4+CD25+ regulatory 




Male Sprague Dawley (SD) rats (weighing 380~400 g; 
13~14 weeks of age) were used for all experiments. All animal 
procedures were carried out according to a protocol approved 
by the Yonsei University Animal Care and Use Committee 
in accordance with NIH guidelines. Th ree groups of animals 
were established: normal control (N=4), experimental control 
(N=4), and agmatine treatment (N=4).
Transient cerebral ischemia rat model
Animals were anesthetized with Zoletil (tiletamine 
hydrochloride, 300 mg/kg) intramuscularly. The depth 
of anaesthesia was assessed by toe pinch, and the rectal 
temperature was monitored during transient middle cerebral 
artery occlusion. Transient cerebral ischemia was induced 
using an occluding intraluminal suture, as previously 
described (Kim et al., 2004). Briefly, an uncoated 4.0 nylon 
monofi lament suture with a round tip was inserted into the 
arteriotomy and advanced under direct visualization into 
the internal carotid artery, 20 mm from the bifurcation, to 
occlude the ostium of the middle cerebral artery. After 1 
hour, the suture was withdrawn and the surgical incisions 
were closed. Agmatine (100 mg/kg; Sigma) were injected 
intraperitoneally at the end of occlusion aft er the suture was 
removed. The experimental control group received saline 
using the same method.  Aft er 23 hours, these animals were 
sacrifi ced for analysis.
Infarct volume quantifi cation
The brain was removed and consecutively sectioned in 
2-mm thicknesses. The 2nd, 4th, and 6th sections of a total 
of 6 coronal serial sections were stained with 2% triphenyl 
tetrazolium chloride (TTC) solution for 30 min at 37oС 
aft er fi xation with 4% paraformaldehyde. Brain swelling and 
infarction volumes were determined using a computerized 
image analysis system (Image J, NIH image, version 1.36). 
Th e volume of infarction was expressed as a percentage of the 
total brain volume and the volumes of the contralateral and 
ipsilateral hemispheres were similarly expressed. 
Sample preparation 
The intact spleens were extirpated and fixed in 4% 
paraformaldehyde and immersed in serial solutions of 20% 
and 30% saccharose at 4oC with constant shaking on a shaker. 
The tissues were embedded in a special tissue protecting 
Alginate embedding material (Histomer; Histotech, Egaa, 
Denmark) and coronally-sectioned in 2-mm thicknesses. 
Alternate tissue slices were obtained for analysis. Th e spleens 
of the experimental control, agmatine treatment, and normal 
control groups were sectioned into 16~18 pieces, 14~16 
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pieces, and 8~9 pieces, respectively. The tissue slices were 
embedded in OCT compound and sectioned in 40-μm 
thicknesses to obtain 10 consecutive serial sections from each 
tissue slice using a cryotome.
 
Histologic staining and immunohistochemistry
Th e fi rst tissue section was stained with hematoxylin-eosin. 
Single eosin staining was adequately done in a second tissue 
section to measure the white and red pulp areas of the spleen. 
Eosin-stained spleen sections were photographed in the gray 
mode using a digital camera under a microscope. White 
and red pulp areas were distinguished and calculated using 
a computerized image analysis system (Image J, NIH image, 
version 1.36). 
For immunohistochemical analysis, frozen sections of the 
spleen were stained with monoclonal anti-CD11b antibodies 
(Serotec, Oxford, UK) and polyclonal anti-CD8+ (BD, 
CA, USA) antibodies against surface antigens of cytotoxic 
T lymphocytes, followed by reaction with an appropriate 
biotinylated secondary antibody. Staining was done using an 
ABC kit (Vector, CA, USA; Lee et al., 2001), then diamino-
benzidine (DAB; Sigma) was used as a chromogen. To 
determine the number of T reg cells in the white pulp area, 
splenic tissue was double immune-stained with anti-CD4+ 
and CD25+ antibodies (BD), followed by an appropriate 
biotinylated secondary antibody.  Stains were visualized 
using an ABC-AP kit (Vector) with BCIP/NBT and Fast Red 
substrates. 
Cell count and unbiased stereologic analysis
To assess CD11b, CD8, or CD4, CD25-positive cells in 
the white plup of the spleen were counted with an optical 
fractionator (West, 1993). The CAST grid system was 
equipped with an Olympus BX51 microscope, a motorized 
microscope stage run by an IBM-compatible computer, and 
a microcator (Olympus, Japan) connected to the stage to 
provide distance information for the z-axis (Kim et al., 2006; 
Garcia et al., 2007). Th e entire white pulp of the spleen, with 
the exception of the red pulp of spleen, was delineated with 
a 1.25× objective and a counting grid of 300×300 μm. An 
unbiased counting frame of known area (48.6×36.1 μm= 
1757 μm2) superimposed on the image was placed randomly 
over the fi rst counting area and moved systematically over all 
counting areas until the entire delineated area was sampled. 
The stereologic cell counting method was a 3-dimensional 
image system and cells on the green line were counted, but 
cells on the red line were not counted. The area sampling 
fraction was 1.89%. Th e section thickness was 40 μm. 
Statistical analysis
Statistical tests to determine diff erences between 3 groups 
were performed by a one-way ANOVA (Student-Newman-
Keuls multiple-range test) using SPSS, version 13.0 (SPSS, 
Chicago, IL, USA). A p value<0.05 was considered signifi cant. 
Data are expressed as the mean±standard error of the mean 
(SEM).
Results
Infarction area on cerebral ischemia
Rat brain tissue was stained by TTC staining (Fig. 1) for 
the evaluation of the infarct area. The infarction area was 
analyzed 23 hours after transient cerebral ischemia. The 
infarction area was signifi cantly reduced (5.51±1.63% of the 
entire brain) in the agmatine treatment group compared to 
15.02± 4.28% in the entire brain in the experimental control 
group (Table 1). The brain swelling volume [ipsilateral 
Table 1. Infarction area of the brain 23 hours after transient cerebral 
ischemia





Normal control 49.86±0.98 51.34±2.06 0
Experimental control 47.88±0.93 53.29±0.33 15.02±4.28
Agmatine treatment 48.44±0.06 51.59±0.82   5.51±1.63
Fig. 1. TTC staining of the ischemic injured brain with or without 
agmatine treatment. Agmatine treatment reduced the infarction (white 
color area) 23 hours after transient cerebral ischemia compared to 
experimental control. NC, Normal control group; EC, Experimental 
control group; AGM, Agmatine treatment group.
Th e eff ect of agmatine on spleen aft er stroke
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hemisphere volume/contralateral hemisphere volume×100 
(%)] was also reduced in the agmatine treatment group 
compared to the experimental control group (Table 1). The 
infarction area was expressed as a percentage of the total area 
of the brain 23 hours aft er transient cerebral ischemia and the 
values are presented in Table 1. 
Th e changes in red and white pulp areas of the rat 
spleen 23 hours aft er transient cerebral ischemia
Clearly segregated red and white pulp was shown in the 
normal control group with hematoxylin-eosin staining. The 
red pulp had no blood overbrimming in the normal control 
group. In the experimental control group, overbrimmed 
blood was noted and a large number of erythrocytes were 
shown inside the vessels. Th e white pulp area was rare and not 
clear compared to the normal control and agmatine treatment 
groups (Fig. 2). 
Under high magnifi cation, sinusoidal capillaries around the 
PALS and the mantle zone appeared wide in the experimental 
control group compared to the agmatine treatment group. In 
the agmatine treatment group, the red and white pulp map 
was clearly distinguished with hematoxylin-eosin staining 
and the area of the white pulp in the spleen was increased 
compared to the experimental control group. Under high 
magnification, the mantle and marginal zones in the 
agmatine treatment group appeared thick compared to the 
experimental control group (Fig. 2).
Th e white pulp area of the spleen was 92.18±3.52 mm2 in 
the experimental control group and 130.726±18.884 mm2 
in the agmatine treatment group. The white pulp area in 
the agmatine treatment group was similar to the normal 
control group (149.879±9.574 mm2). The red pulp area was 
significantly increased in the experimental control group 
compared to the normal control and agmatine treatment 
Fig. 2. Macrograph of spleen tissue stained with hematoxylin-eosin. Red pulp and white pulp map was clearly distinguished and the number of 
white pulp was increased in agmatine treatment group compared to experimental control group. Scale bar is 200 μm. NC, Normal control group; 
EC, Experimental control group; AGM, Agmatine treatment group.
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groups. However, the white pulp area was significantly 
increased in the agmatine treatment group compared to the 
experimental control group (Fig. 3). 
Th e evaluation of exposed macrophages in the white 
pulp area with anti-CD11b monoclonal antibody
Under low magnification (12.5X) under a stereologic 
microscope, the white pulp area of the spleen appeared 
to be surrounded by red pulp. The number of CD11b+ 
macrophages which stained deep brown was analyzed by 
the CAST counting analysis method. The red and white 
pulp areas of the rat spleen tissue were clearly distinguished 
in the normal control and agmatine treatment groups with 
immunohistochemial staining with anti-CD11b antibody, but 
not in the experimental control group (Fig. 4A). 
The total  number of  CD11b+ macrophages was 
42,768,959.43± 12,498,370 in the normal control group and 
Fig. 3. The percentage of red and white pulp areas of the spleen 23 
hours aft er transient cerebral ischemia. Agmatine treatment signifi cantly 
increased the white pulp area and decreased the red pulp area 23 hours 
after transient cerebral ischemia compared to experimental control 
group. NC, Normal control group; EC, Experimental control group; 
AGM, Agmatine treatment group (*P<0.05 vs EC; †P<0.05 vs NC and 
AGM).
Fig. 4. Th e change of CD11b+ macrophages in the spleen 23 hours aft er transient cerebral ischemia. (A) Macrograph of CD11b+ macrophages in 
the spleen 23 hours aft er transient cerebral ischemia. Agmatine treatment reduced CD11b+ macrophages (brown) in the white pulp compared to 
the experimental control group. (B) in the experimental control group, the total number of CD11b+ macrophages was increased in the white pulp 
of whole spleen compared to the normal control group, but the total number of CD11b+ macrophages was decreased in the agmatine treatment 
group compared to the experimental control group. (C) Th e number of CD11b+ macrophages per unit volume in the white pulp of the spleen was 
the highest in the experimental control group and it was signifi cantly decreased in the agmatine treatment group compared to the normal control 
group. Scale bar is 50 μm. NC, Normal control group; EC, Experimental control group; AGM, Agmatine treatment group (*P<0.05 vs EC).
Th e eff ect of agmatine on spleen aft er stroke
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the number of CD11b+ macrophages per unit volume was 
103.77±31.19 cells/mm3. In the experimental control group, 
the total number of CD11b+ macrophages in the white pulp 
area was increased to 111,268,135.09±61,349,219.9, and the 
number of CD11b+-positive cells per unit volume was also 
increased to 428.8±241.01 cells/mm3 compared to the normal 
control group. This elevation was reduced in the agmatine 
treatment group. The number of CD11b+ macrophages in 
the agmatine treatment group was signifi cantly decreased to 
39,213,403.88 ±23,167,840.6, and the number of CD11b+-
positive cells per unit volume was decreased to 95.65±38.87 
cells/mm3 compared to the experimental control group (Fig. 
4B, C). 
Evaluation of exposed T reg cells of the white pulp 
area with anti-CD4+CD25+ antibodies
The activated T reg cells in the white pulp area were 
immunostained with the double staining method using anti-
CD4+ and anti-CD25+ antibodies. Anti-CD4+ antibody for 
CD4+ T cells was developed with NABP/FR reagent (red 
color) and anti-CD25+ antibody for CD25+ T cells with 
BCIP/NBT reagent (blue color).
The CAST counting analysis data displayed that 
CD4+CD25+ double-positive T reg cells were few in number 
in the normal control group, but a greater number of double-
positive cells was detected in the vessels (Fig. 5A). 
The total number of CD4+CD25+ T reg cells was 
395,061.72± 78,936.72 and the number of CD4+CD25+ T reg 
cells per unit volume was 1.09±0.23 cells/mm3 in the normal 
control group. The total number of CD4+CD25+ T reg 
cells was clearly increased in the white pulp of the spleen to 
7,677,363.69 ±2,172,451.44 and the number of CD4+CD25+ 
T reg cells per unit volume was  increased to 29.78±8.43 cells/
mm3 in the experimental control group compared to the 
Fig. 5. Th e change of CD4+CD25+ T reg cells in the spleen 23 hours aft er transient cerebral ischemia. (A) Macrograph of CD4+CD25+ T reg cells 
in the spleen 23 hours aft er transient cerebral ischemia. Agmatine treatment reduced CD4+CD25+ T reg cells (purple) in the white pulp compared 
to experimental control group. (B) In the experimental control group, the total number of CD4+CD25+ T reg cells was increased in the white 
pulp of the entire spleen compared to the normal control group, but the total number of CD4+CD25+ T reg cells was decreased in the agmatine 
treatment group compared to the experimental control group. (C) Th e number of CD4+CD25+ T reg cells per unit volume in the white pulp 
of the spleen was the highest in the experimental control group and it was signifi cantly decreased in the agmatine treatment group as the normal 
control group. Scale bar is 50 μm. NC, Normal control group; EC, Experimental control group; AGM, Agmatine treatment group (*P<0.05 vs 
EC).
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60,758,377.43±20,065,259.45 cells was observed in the 
agmatine treatment group (Fig. 6B). 
The number of CD8+ CTLs per unit volume was 
89.27±17.32 cells/mm3 in the normal control group. The 
number in the experimental control group was increased 
to 189.75±75.85 cells/mm3 compared to the normal control 
group, but the increase was not significant. However, 
agmatine treatment also reduced the number of CD8+ CTLs 
per unit volume to 151.44±29.94 cells/mm3 and the increase 
was also not signifi cant (Fig. 6C). 
 
Discussion 
In this study, we moved our focus for studying the eff ect of 
agmatine on cerebral ischemia from the brain to the spleen 
(the core of immune reactions). Th e spleen could contribute 
to the expansion of infarct size after a stroke through 
normal control group. The total number of CD4+CD25+ T 
reg cells were markedly reduced by agmatine treatment to 
312,169.31± 47,687.58 and the number of CD4+CD25+ T 
reg cells per unit volume was reduced to 0.98±0.16 cells/mm3 
similar to the number in the normal control group (Fig. 5B, C). 
Evaluation of exposed cytotoxic T lymphocytes 
(CTLs) of the white pulp area with anti-CD8+ 
monoclonal antibody
CTLs were detected using anti-CD8+ monoclonal antibody 
and were developed with the DAB reaction and analyzed by 
CAST counting analysis. CD8+ CTLs were in rows along the 
vessels in the white pulp area of the rat spleen (Fig. 6A).
The total number of CD8+ CTLs in the white pulp 
area of the whole spleen was 35,723,104.06±3,292,321.16 
in the normal control group. The number of CD8+ 
CTLs in the experimental  group was increased to 
49,215,014.19±19,326,026.17 and a further increase to 
Fig. 6. Th e change of CD8+ CTLs in the spleen 23 hours aft er transient cerebral ischemia. (A) Macrograph of CD8+ CTLs in the spleen 23 hours 
aft er transient cerebral ischemia. CD8+ CTLs (brown) were increased in the experimental control and agmatine treatment groups compared to the 
normal control group. (B) in the experimental control group, the total number of CD8+ CTLs was increased in the white pulp of the entire spleen 
compared to the normal control group, but it was not signifi cant. Th e total number of CD8+ CTLs in the agmatine treatment group was increased 
without signifi cance. (C) Th e number of CD8+ CTLs per unit volume in the white pulp of the spleen was the highest in the experimental control 
group, but it was not significant among all groups. Scale bar is 50 μm. NC, Normal control group; EC, Experimental control group; AGM, 
Agmatine treatment group.
Th e eff ect of agmatine on spleen aft er stroke
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activation of the sympathetic nervous system, resulting in 
splenic contraction and a potential release of red and white 
blood cells (Stewart & McKenzie, 2002). This contraction 
causes a release of pro-infl ammatory immune cells, which are 
attracted to the brain by cytokines induced by stroke. 
After a stroke, the splenic reservoir and filtration are 
enhanced and active macrophages are increased, and brain 
inflammation was induced in the experimental control 
group. Macrophages do not only present antigens to helper T 
cells, phagocytose, and secrete pro-inflammatory cytokines, 
but also initiate immune response reaction, activation, 
suppression, and termination (Batbaatar, 2007). In our study, 
the total number of CD11b+ macrophages was higher in 
the experimental control and agmatine treatment groups; 
the total number of CD11b+ macrophages was decreased. 
However, the splenic red pulp area was enlarged to 77.07% 
with activity of the splenic reservoir and filtration function 
and the white pulp area was reduced to 23.3% in the 
experimental control group compared to the normal control 
group. Agmatine treatment decreased the expansion of red 
pulp to 66.6% and reduced the contraction of the white pulp 
area to 34.26%, similar to the normal condition 23 hours aft er 
transient cerebral ischemia. Also, PALS and the mantle zone 
were thickened in the agmatine treatment group compared 
to the experimental control group. Th e peri-arteial lymphoid 
sheaths and marginal zones are predominantly composed 
of T lymphocytes. A few T cells are scattered in germinal 
centers and in the mantle zones. T helper cells predominate 
in these areas with a ratio of T helper-to-T suppressor cells 
of 3 : 1 to 4 : 1.  Th ere is some spill over of T cells into the red 
pulp. Red pulp T cells are mainly suppressor/cytotoxic cells. 
Only occasional suppressor cells are found in the PALS, and 
they are virtually absent from the germinal centers (Wolf & 
Neiman, 1987).
Aft er stroke, there is a depression of the immune system, 
often resulting in infection and subsequent death. This 
complication that the change of spleen after stroke may 
induce post-stroke infection is not well-studied in the 
field. In a mouse transient cerebral ischemia model, post-
stroke immunodeficiency was caused by activation of the 
sympathetic nervous system and a systemic apoptotic loss 
of interferon gamma-secreting T lymphocytes (Prass et 
al., 2003). Sakaguchi et al. (1995) rekindled interest in the 
concept of T-cell-mediated suppression in the mid-1990s 
by showing that a minor population (~10 %) of CD4+ T 
cells, which co-expresses the interleukin-2 receptor (IL-2R) 
α-chain (CD25), is crucial for the control of autoreactive T 
cells in vivo. Subsequent in vitro studies by several groups 
showed that CD4+CD25+ T cells are both hyporesponsive 
and suppressive (Takahashi et al., 1998; Th ornton & Shevach, 
1998). CD4+CD25+ T cells were discovered originally in mice, 
but a population with identical phenotypic and functional 
properties has been defined recently in humans (Levings et 
al., 2001). Although the term ‘regulatory T cell’ was replaced 
by the term ‘suppressor T cell’ in the immunology literature, 
T reg cells might enhance or suppress immune responses. 
T reg cells recognize self-antigens, and are generated by 
recognition of self-antigens. In many experimental models, 
the function of T reg cells also appears to depend on the 
cytokine, TGFβ, which inhibits the responses of CD4+ T cell, 
CD8+ T lymphocytes, and macrophages (Abbas, 2007). In our 
present study, the number of T reg cells was increased in the 
experimental control group 23 hours aft er transient cerebral 
ischemia, suggesting that the systemic immune response 
was reduced, so the possibility of post-stroke infection will 
increase. Agmatine treatment reduced the number of T reg 
cells in the white pulp of the spleen, so the chance of post-
stroke infection may be reduced. 
It could be expected that induced infl ammatory cells from 
the spleen were pierced through the blood-brain barrier and 
entered into the ischemic injured site, these blood elements 
were exposed by microglia, such as an autoantigens, and 
against these autoantigens autoimmune reaction was activated 
and increases the number of T reg cells. Agmatine has been 
reported to block the blood-brain barrier disruption by 
suppressing the expression of matrix metalloproteinase aft er 
transient cerebral ischemia (Kim et al., 2008). It is possible 
to explain that the number of CD4+CD25+ T reg cells per 
volume was reduced to 0.98±0.16 cells/mm3 in the agmatine 
treatment group compared to the experimental control group 
(29.78±8.43 cells/mm3).
The CD8 antigen is a cell surface glycoprotein found 
mostly on cytotoxic T lymphocytes that mediates efficient 
cell-to-cell interactions within the immune system. CD4+ T 
cells and CD8+ T cells recognize peptides that are derived 
from protein antigens and presented by professional APCs 
(macrophages) into the spleen. Differentiated CTLs are 
capable of secreting cytokines, mostly IFNγ, lymphotoxin, 
and TNF, which function to activate phagocytes and induce 
infl ammation. 
CD8+ CTLs effector functions by directly attacking 
infected cells, whereas a single CD4+ helper cell may 
Anat Cell Biol 43:44~53, 2010 D Uranchimeg, et al52
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secrete cytokines that activate many effector cells, such as 
macrophages, and therefore a greater number of CTLs may 
be needed for protective immunity. In our experiment, 
the number of CD8+ CTLs per unit volume was increased 
23 hours after transient cerebral ischemia, but agmatine 
treatment cannot significantly affect the number of CD8+ 
CTLs per unit volume.
In conclusion,  agmatine treatment reduced the 
contraction of white pulp in the spleen and decreased the 
number of macrophages in the white pulp of the spleen, 
leading to reducing brain infarction through minimizing 
neuroinflammation after stroke. In addition to reducing 
brain infarction aft er stroke, agmatine treatment reduced the 
number of T reg cells in the white pulp of the spleen, proving 
that agmatine treatment can lessen the danger of post-stroke 
infection from depression of the immune system aft er stroke. 
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